
Agilent Technologies
North America, California, United States, Santa Clara
Description
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Investor Profile
Agilent Technologies has backed more than 37 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 16% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, France.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series B (35%)
- Series A (22%)
- Series C (19%)
- Series Unknown (11%)
- Private Equity (5%)
- Series D (3%)
- Series G (3%)
- Seed (3%)
Country Focus
- United States (84%)
- United Kingdom (5%)
- France (5%)
- Germany (3%)
- Canada (3%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Genetics
- Manufacturing
- Medical
- Wireless
- Health Diagnostics
- Internet
- Analytics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.